The main subject discussed during this session is the treatment of complex patients, comorbidities, and the impact on hemostasis.
When it comes to statistics regarding bleeding situations, we can observe that between 32% and 68% of cases in open surgeries experience complex bleeding effects. Uncontrolled surgical bleeding is associated with high mortality rates and associated complications increase resource utilization.
Furthermore, the optimal use of available hemostatic options may lead to significant hospital cost savings when it comes to controlling surgical bleeding. There are also many patient factors that contribute significantly to the increased risk of surgical bleeding due to comorbidities: uncontrolled diabetes, obesity, and cancer are some of the conditions that affect the natural clotting process.
Bearing in mind that patients can be on a number of medications, these can also increase the risk of surgical bleeding. Patient medications may lead to surgical bleeding in approximately 10% to 25% of procedures. A sheet with the hospital-related costs is also provided for reference.
To summarize, Dr. Grayson Wheatley gives an overview of the types of bleeding and points out the primary and adjunctive methods that are required in different bleeding solutions.
Share it with your network and help spread clinical knowledge.
